GW Pharma, Mentor Capital and Terra Tech lead in NASDAQ Comparison
Mentor Capital, Inc. (OTCQB:MNTR) announces that the leaders in Mentor’s
new Cannabis Index for Value Investors were Mentor Capital at (252%),
Terra Tech (OTCQX:TRTC) at (86%) and GW Pharmaceuticals Plc. (NASDAQ:
GWPH) at (33%) when compared to the NASDAQ average set at (100%). Sales
plus book value were compared to market capitalization for leading
marijuana stocks to establish this new marijuana stock index.
“The Mentor Capital Cannabis Index for Value Investors is intended to
provide an alternative business value focused metric for investors to
examine, as opposed to the plethora of share price tracking compilations
common around cannabis stocks. Momentum, technical analysis, day trading
and chart watching are susceptible to stock manipulation schemes while
value investing is less so,” counsels Mentor CEO, Chet Billingsley.
“Mentor Capital is pleased that our value focused investment approach
has paid off in increasing Mentor book value and revenue per share
ratios which now more than double that of the Nasdaq Composite Index,
which itself outstrips typical cannabis ratios.
“For interested investors, we will publish our cannabis index and
comparative value oriented ratios at our company website regularly,”
affirms Billingsley. “As required, Mentor does not provide any
investment advisory, purchase or price recommendations from the
historical financial information we portray.” Other marijuana stocks of
interest and their respective ratios to NASDAQ in the growing index
include: Cannabis Science Inc. (OTCMkts:CBIS) at (-20); Hemp, Inc.
(OTCMkts:HEMP) at (10%); MassRoots, Inc. (OTCQB:MSRT) at (3%); and
Medbox, Inc. (OTCQB:MDBX) at (-684%).
About Mentor Capital: The Company seeks to come alongside and
assist medical marijuana and cannabis companies and their founders in
meeting their financial objectives, to add protection for investors and
to help incubate private cannabis companies. Additional important
information for investors is presented at: www.MentorCapital.com
.
This press release is neither an offer to sell, nor a solicitation of
offers to purchase, securities.
Forward Looking Statements: This press release contains
forward-looking statements within the meaning of the federal securities
laws, including statements concerning financial projections, financing
activities, corporate combinations, product development activities and
sales and licensing activities. Such forward-looking statements
are not guarantees of future results or performance, are sometimes
identified by words of condition such as “should,” “could,” “expects,”
“may,” “intends,” “seeks,” “looks,” “moves,” or “plans” and are subject
to a number of risks and uncertainties, known and unknown, that could
cause actual results to differ materially from those intended or
anticipated. Such risks include, without limitation:
nonperformance of investments, partner and portfolio difficulties,
potential delays in marketing and sales, problems securing the necessary
financing to continue operations, problems involving continued
illegality of cannabis products, potential of competitive
products, services, and technologies, difficulties experienced in
product development, in recruiting knowledgeable personnel and in
protecting intellectual property. Further information concerning
these and other risks is included in the Company’s 10-K and 10-Q filings
including the Company’s most recent Quarterly Report on Form 10-Q for
the quarter ended September 30, 2015 which, along with other very
important information about the Company, can be found filed with the SEC
and here:
http://mentorcapital.com/disclosures/
The Company undertakes no obligation to update or revise such
forward-looking statements to reflect new information, events or
circumstances occurring after the date of this press release.
View source version on businesswire.com: http://www.businesswire.com/news/home/20151211005538/en/
Copyright Business Wire 2015